SMAD4 and neoplasm: The theory, which is advocated by our findings, proclaims that Act-A may deter the advance of Smad4-positive tumours, whilst it could induce progression through non-canonical oncogenic pathways following the loss of Smad4 protein during the late stages of CRC [10, 35, 36].